Who owns Threshold Pharmaceuticals?

Key details on Threshold Pharmaceuticals (Ticker: THLD)

Who owns Threshold Pharmaceuticals?

Is THLD a good stock to own? Find out who bought Threshold Pharmaceuticals, who sold Threshold Pharmaceuticals (THLD) stock, and who holds a large position in Threshold Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
JPMORGAN CHASE & CO 3.16M $14.75M Dec. 31, 2013
Federated Investors 3.04M $14.18M Dec. 31, 2013
FMR 2.55M $11.92M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 2.00M $9.36M Dec. 31, 2013
Baker Bros. Advisors 1.85M $8.65M Dec. 31, 2013
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.82M $8.48M Dec. 31, 2013
Franklin Resources 1.68M $7.85M Dec. 31, 2013
Wells Fargo & Company 1.50M $11.12M June 30, 2012
Adage Capital Partners GP 1.38M $7.28M June 30, 2013
Vanguard 1.31M $6.12M Dec. 31, 2013
BlackRock Fund Advisors 1.29M $6.02M Dec. 31, 2013
STATE STREET CORPORATION 1.24M $5.78M Dec. 31, 2013
PointState Capital 1.20M $10.56M March 31, 2012
T. Rowe Price Associates 1.05M $4.89M Sept. 30, 2013
Ayer Capital Management 792846 $3.34M Dec. 31, 2012
Columbus Circle Investors 731394 $3.08M Dec. 31, 2012
S.A.C. Capital Advisors 705800 $5.22M June 30, 2012
Millennium Management 697279 $3.26M Dec. 31, 2013
VHCP Management 684000 $3.18M Sept. 30, 2013
NORTHERN TRUST 671589 $3.15M Dec. 31, 2013
AXA 581068 $2.71M Dec. 31, 2013
DAFNA Capital Management 571428 $4.23M June 30, 2012
Straus Capital Management 509101 $2.14M Dec. 31, 2012
Royal Bank of Canada 495974 $2.32M Dec. 31, 2013
Barclays 483600 $2.23M March 31, 2013
Thomas Weisel Asset Management 466713 $3.38M Sept. 30, 2012
CR Intrinsic Investors 454258 $2.11M Sept. 30, 2013
MORGAN STANLEY 435242 $2.04M Dec. 31, 2013
Oxford Asset Management 421856 $1.78M Dec. 31, 2012
BlackRock Advisors 410894 $1.92M Dec. 31, 2013
Austin W. Marxe and David M. Greenhouse 400000 $3.52M March 31, 2012
Polar Capital 360000 $2.66M June 30, 2012
TIAA-CREF Investment Management 359664 $1.67M Sept. 30, 2013
D. E. Shaw & Co 344440 $1.61M Dec. 31, 2013
NUMERIC INVESTORS 321100 $2.83M March 31, 2012
Deutsche Bank Aktiengesellschaft 316427 $1.48M Dec. 31, 2013
SUSQUEHANNA INTERNATIONAL 313467 $1.46M Dec. 31, 2013
Driehaus Capital Management 313181 $1.44M March 31, 2013
Jefferies 270400 $2.00M June 30, 2012
Renaissance Technologies 269864 $1.25M Sept. 30, 2013
AQR Capital Management 257295 $1.35M June 30, 2013
Rhenman & Partners Asset Management AB 250000 $1.17M Dec. 31, 2013
Ellington Management 243100 $1.76M Sept. 30, 2012
PUTNAM INVESTMENTS 223465 $1.04M Dec. 31, 2013
Technical Financial Services 223132 $1.17M June 30, 2013
Credit Suisse AG 222109 $1.04M Dec. 31, 2013
UBS AG 216032 $1.90M March 31, 2012

Who sold Threshold Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
GRT Capital Partners June 30, 2011 305095 $509508